FRI214 - Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis.

Authors :: Alkhouri, Naim
Wong, Vincent Wai-Sun
Jablkowski, Maciej
de Guevara, Alma Laura Ladrón
Sheikh, Muhammad
Hodge, Alex
Elkhashab, Magdy
Strasser, Simone
Park, Grace S.
Landgren, Henrik
Tan, Bill
Massetto, Benedetta
Pecoraro, Maria Lucia
Seyedkazemi, Star
Martins, Eduardo Bruno
Fischer, Laurent
Abdelmalek, Manal
Tetri, Brent
Anstee, Quentin
Source :: Journal of Hepatology. 2020 Supplement 1, Vol. 73, pS508-S508. 1p.
Publication Year :: 2020

Full Text Access

Tools